aod9604 development discontinued AOD-9604 5mg Produced using quality AOD-9604 Australia 5mg hGH Fragment

Pairs well with Epitalon for a multi-pathway anti-aging approach

This population-specific safety evidence is more relevant for clinical application than data from exclusively healthy volunteers would be

A knockdown study and a small-molecule mouse study are exactly the steps that should precede a human trial, and they are the reason a compound gets taken seriously enough to be studied further

The peptide is dosed once daily as a subcutaneous injection, usually before bed or first thing in the morning to align with natural lipolytic windows

Published clinical trials used continuous daily administration for 12-24 weeks without scheduled breaks, establishing this as a viable approach with maintained safety throughout the treatment period

Safety Profile for Metabolic Health The preservation of normal glucose metabolism makes AOD-9604 particularly valuable for individuals with metabolic syndrome, insulin resistance, pre-diabetes, or type 2 diabetes who seek fat loss support